ALBEMARLE CORP(NYSE:ALB) stock Fundamental Analysis

Fundamental Rating

Overall ALB gets a fundamental rating of 3 out of 10. We evaluated ALB against 85 industry peers in the Chemicals industry. Both the profitability and financial health of ALB have multiple concerns. While showing a medium growth rate, ALB is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALB had negative earnings in the past year.

ALB had a positive operating cash flow in the past year.

ALB had positive earnings in 4 of the past 5 years.

ALB had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -7.92%, ALB is doing worse than 80.72% of the companies in the same industry.

ALB has a worse Return On Equity (-13.21%) than 78.31% of its industry peers.

		Industry Rank	Sector Rank
ROA	-7.92%
ROE	-13.21%
ROIC	N/A

ROA(3y)6.03%

ROA(5y)4.56%

ROE(3y)12.4%

ROE(5y)9.64%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 1.19%, ALB is not doing good in the industry: 89.16% of the companies in the same industry are doing better.

In the last couple of years the Gross Margin of ALB has declined.

ALB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	1.19%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-66.02%

GM growth 5Y-49.18%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALB does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ALB has about the same amount of shares outstanding.

The number of shares outstanding for ALB has been increased compared to 5 years ago.

Compared to 1 year ago, ALB has an improved debt to assets ratio.

2.2 Solvency

ALB has an Altman-Z score of 1.67. This is a bad value and indicates that ALB is not financially healthy and even has some risk of bankruptcy.

ALB has a Altman-Z score of 1.67. This is in the lower half of the industry: ALB underperforms 61.45% of its industry peers.

A Debt/Equity ratio of 0.31 indicates that ALB is not too dependend on debt financing.

ALB's Debt to Equity ratio of 0.31 is fine compared to the rest of the industry. ALB outperforms 71.08% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.31
Debt/FCF	N/A
Altman-Z	1.67

ROIC/WACCN/A

WACC8.38%

2.3 Liquidity

A Current Ratio of 1.95 indicates that ALB should not have too much problems paying its short term obligations.

ALB's Current ratio of 1.95 is in line compared to the rest of the industry. ALB outperforms 46.99% of its industry peers.

A Quick Ratio of 1.19 indicates that ALB should not have too much problems paying its short term obligations.

The Quick ratio of ALB (1.19) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	1.95
Quick Ratio	1.19

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -110.52%.

Looking at the last year, ALB shows a very negative growth in Revenue. The Revenue has decreased by -44.08% in the last year.

The Revenue has been growing by 8.42% on average over the past years. This is quite good.

EPS 1Y (TTM)-110.52%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-158.92%

Revenue 1Y (TTM)-44.08%

Revenue growth 3Y17.35%

Revenue growth 5Y8.42%

Sales Q2Q%-47.72%

3.2 Future

The Earnings Per Share is expected to grow by 71.51% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 14.01% on average over the next years. This is quite good.

EPS Next Y79.84%

EPS Next 2Y74.44%

EPS Next 3Y59.2%

EPS Next 5Y71.51%

Revenue Next Year-5.8%

Revenue Next 2Y4.19%

Revenue Next 3Y6.8%

Revenue Next 5Y14.01%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALB. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALB. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ALB's earnings are expected to grow with 59.20% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y74.44%

EPS Next 3Y59.2%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALB has a Yearly Dividend Yield of 1.94%. Purely for dividend investing, there may be better candidates out there.

In the last 3 months the price of ALB has falen by -25.08%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.

ALB's Dividend Yield is a higher than the industry average which is at 3.27.

Compared to an average S&P500 Dividend Yield of 2.29, ALB has a dividend comparable with the average S&P500 company.

		Industry Rank	Sector Rank
Dividend Yield	1.94%

5.2 History

The dividend of ALB is nicely growing with an annual growth rate of 13.04%!

ALB has been paying a dividend for at least 10 years, so it has a reliable track record.

ALB has not decreased their dividend for at least 10 years, which is a reliable track record.

Dividend Growth(5Y)13.04%

Div Incr Years30

Div Non Decr Years30

5.3 Sustainability

ALB has negative earnings and hence a negative payout ratio. The dividend may be in danger.

ALB's earnings are growing more than its dividend. This makes the dividend growth sustainable.

DP-23.65%

EPS Next 2Y74.44%

EPS Next 3Y59.2%

More info and screens

Find the best dividend stocks

Show peers with best dividend

ALBEMARLE CORP

NYSE:ALB (2/21/2025, 4:50:23 PM)

After market: 81.2 0 (0%)

81.2

-1.31 (-1.59%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)02-12 2025-02-12/amc

Earnings (Next)04-29 2025-04-29/amc

Inst Owners95.31%

Inst Owner Change7%

Ins Owners0.22%

Ins Owner Change-0.5%

Market Cap9.54B

Analysts68.75

Price Target100.59 (23.88%)

Short Float %11.23%

Short Ratio5.9

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.94%

Yearly Dividend2.65

Dividend Growth(5Y)13.04%

DP-23.65%

Div Incr Years30

Div Non Decr Years30

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-151.9%

Min EPS beat(2)-249.28%

Max EPS beat(2)-54.53%

EPS beat(4)0

Avg EPS beat(4)-99.35%

Min EPS beat(4)-249.28%

Max EPS beat(4)-3.3%

EPS beat(8)3

Avg EPS beat(8)-29.85%

EPS beat(12)7

Avg EPS beat(12)-15.03%

EPS beat(16)11

Avg EPS beat(16)-6.38%

Revenue beat(2)0

Avg Revenue beat(2)-5.48%

Min Revenue beat(2)-8.69%

Max Revenue beat(2)-2.26%

Revenue beat(4)2

Avg Revenue beat(4)-0.58%

Min Revenue beat(4)-8.69%

Max Revenue beat(4)5.88%

Revenue beat(8)3

Avg Revenue beat(8)-1.78%

Revenue beat(12)4

Avg Revenue beat(12)-1.45%

Revenue beat(16)6

Avg Revenue beat(16)-0.36%

PT rev (1m)-1.52%

PT rev (3m)0.48%

EPS NQ rev (1m)-8.63%

EPS NQ rev (3m)-56.08%

EPS NY rev (1m)-2.85%

EPS NY rev (3m)-203.02%

Revenue NQ rev (1m)-1.75%

Revenue NQ rev (3m)-6.71%

Revenue NY rev (1m)-0.25%

Revenue NY rev (3m)-1.04%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.77
P/FCF	N/A
P/OCF	13.59
P/B	0.96
P/tB	1.17
EV/EBITDA	N/A

EPS(TTM)-2.34

EYN/A

EPS(NY)-0.47

Fwd EYN/A

FCF(TTM)-8.37

FCFYN/A

OCF(TTM)5.97

OCFY7.36%

SpS45.75

BVpS84.75

TBVpS69.32

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.92%
ROE	-13.21%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	1.19%
FCFM	N/A

ROA(3y)6.03%

ROA(5y)4.56%

ROE(3y)12.4%

ROE(5y)9.64%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-66.02%

GM growth 5Y-49.18%

F-Score4

Asset Turnover0.32

Health

		Industry Rank	Sector Rank
Debt/Equity	0.31
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	286.39%
Cap/Sales	31.35%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.95
Quick Ratio	1.19
Altman-Z	1.67

F-Score4

WACC8.38%

ROIC/WACCN/A

Cap/Depr(3y)401.9%

Cap/Depr(5y)389.55%

Cap/Sales(3y)23.64%

Cap/Sales(5y)25.35%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-110.52%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-158.92%

EPS Next Y79.84%

EPS Next 2Y74.44%

EPS Next 3Y59.2%

EPS Next 5Y71.51%

Revenue 1Y (TTM)-44.08%

Revenue growth 3Y17.35%

Revenue growth 5Y8.42%

Sales Q2Q%-47.72%

Revenue Next Year-5.8%

Revenue Next 2Y4.19%

Revenue Next 3Y6.8%

Revenue Next 5Y14.01%

EBIT growth 1Y-237.46%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year165.75%

EBIT Next 3Y59.57%

EBIT Next 5Y40.31%

FCF growth 1Y-19.39%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-47.03%

OCF growth 3Y26.81%

OCF growth 5Y-0.49%

ALBEMARLE CORP (ALB) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens